Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass
- PMID: 8598840
- DOI: 10.1056/NEJM199604183341604
Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass
Abstract
Background: Homozygous carries of the D allele of the angiotensin-converting-enzyme (ACE) gene have been reported to be at increased risk for various cardiovascular disorders, including left ventricular hypertrophy. We investigated the potential role of the ACE gene in influencing left ventricular mass.
Methods: Quantitative echocardiographic data and DNA samples were available for 2439 subjects from the Framingham Heart Study. ACE genotypes were determined by an assay based on the polymerase chain reaction. (The D allele of the ACE gene contains a deletion, whereas the I [insertion] allele does not.) Left ventricular mass and the prevalence of left ventricular hypertrophy, adjusted for clinical covariates, were analyzed according to genotype. Genetic linkage between the ACE locus and left ventricular mass was evaluated by quantitative analysis of pairs of siblings.
Results: The ACE genotype was associated neither with left ventricular mass nor with the prevalence of left ventricular hypertrophy. Mean (+/-SE) left ventricular mass (adjusted for sex) among subjects carrying the DD, DI, and II genotypes was 165+/-1.6, 165+/-1.3, and 166+/-2.0 g, respectively (P=0.90). The prevalence of left ventricular hypertrophy among the three genotype groups was 15.6 percent, 13.6 percent, and 15.6 percent, respectively (P=0.36), and the adjusted relative risk of left ventricular hypertrophy associated with the DD genotype was 1.10 (95 percent confidence interval, 0.86 to 1.19). Linkage analysis in 759 pairs of siblings using both the ACE D/I marker and a microsatellite polymorphism at the neighboring locus for the human growth hormone gene failed to support any role of ACE in influencing left ventricular mass.
Conclusions: The ACE genotype showed no association with echocardiographically determined left ventricular mass, nor did it confer an increased risk of left ventricular hypertrophy. We found no appreciable role of the ACE gene in influencing left ventricular mass.
Comment in
-
Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass.N Engl J Med. 1996 Oct 3;335(14):1070; author reply 1071. doi: 10.1056/NEJM199610033351417. N Engl J Med. 1996. PMID: 8801454 No abstract available.
-
Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass.N Engl J Med. 1996 Oct 3;335(14):1070-1. N Engl J Med. 1996. PMID: 8801455 No abstract available.
Similar articles
-
The Gene Polymorphism of Angiotensin-Converting Enzyme Intron Deletion and Angiotensin-Converting Enzyme G2350A in Patients With Left Ventricular Hypertrophy: A Meta-analysis.Indian Heart J. 2019 May-Jun;71(3):199-206. doi: 10.1016/j.ihj.2019.07.002. Epub 2019 Jul 6. Indian Heart J. 2019. PMID: 31543192 Free PMC article.
-
Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy.N Engl J Med. 1994 Jun 9;330(23):1634-8. doi: 10.1056/NEJM199406093302302. N Engl J Med. 1994. PMID: 8177269
-
Angiotensin-converting enzyme gene polymorphism, left ventricular remodeling, and exercise capacity in strength-trained athletes.Heart Vessels. 2004 Nov;19(6):287-93. doi: 10.1007/s00380-004-0783-7. Heart Vessels. 2004. PMID: 15799176
-
QT dispersion and left ventricular hypertrophy in athletes: relationship with angiotensin-converting enzyme I/D polymorphism.Acta Cardiol. 2005 Aug;60(4):387-93. doi: 10.2143/AC.60.4.2004987. Acta Cardiol. 2005. PMID: 16128371
-
Analysis of gene-environment interactions by "stressing-the-genotype" studies: the angiotensin converting enzyme and exercise-induced left ventricular hypertrophy as an example.Ital Heart J. 2002 Jan;3(1):10-4. Ital Heart J. 2002. PMID: 11899582 Review.
Cited by
-
A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.Pharmacol Rev. 2012 Dec 20;65(1):1-46. doi: 10.1124/pr.112.006809. Print 2013 Jan. Pharmacol Rev. 2012. PMID: 23257181 Free PMC article. Review.
-
Association between ACE and AGT polymorphism and cardiovascular risk in acromegalic patients.Pituitary. 2017 Oct;20(5):569-577. doi: 10.1007/s11102-017-0819-5. Pituitary. 2017. PMID: 28712073
-
Lack of association between angiotensin converting enzyme (ACE) genotype, serum ACE activity, and haemodynamics in patients with primary pulmonary hypertension.Heart. 2003 Apr;89(4):445-6. doi: 10.1136/heart.89.4.445. Heart. 2003. PMID: 12639879 Free PMC article. No abstract available.
-
The Gene Polymorphism of Angiotensin-Converting Enzyme Intron Deletion and Angiotensin-Converting Enzyme G2350A in Patients With Left Ventricular Hypertrophy: A Meta-analysis.Indian Heart J. 2019 May-Jun;71(3):199-206. doi: 10.1016/j.ihj.2019.07.002. Epub 2019 Jul 6. Indian Heart J. 2019. PMID: 31543192 Free PMC article.
-
Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications.Drugs. 2002;62(7):977-93. doi: 10.2165/00003495-200262070-00001. Drugs. 2002. PMID: 11985486 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous